204 related articles for article (PubMed ID: 24956070)
1. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
[TBL] [Abstract][Full Text] [Related]
2. Sparse Principal Component Analysis for the parsimonious description of glucose variability in diabetes.
Fabris C; Facchinetti A; Sparacino G; Cobelli C
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():6643-6. PubMed ID: 25571519
[TBL] [Abstract][Full Text] [Related]
3. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
Crenier L
Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
[TBL] [Abstract][Full Text] [Related]
4. Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.
Fabris C; Facchinetti A; Fico G; Sambo F; Arredondo MT; Cobelli C;
J Diabetes Sci Technol; 2015 Jul; 10(1):119-24. PubMed ID: 26232371
[TBL] [Abstract][Full Text] [Related]
5. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
[TBL] [Abstract][Full Text] [Related]
7. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
[TBL] [Abstract][Full Text] [Related]
8. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
[TBL] [Abstract][Full Text] [Related]
9. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.
Kovatchev B; Cobelli C
Diabetes Care; 2016 Apr; 39(4):502-10. PubMed ID: 27208366
[TBL] [Abstract][Full Text] [Related]
10. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
[TBL] [Abstract][Full Text] [Related]
11. Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus.
Peña NV; Torres M; Cardona JA; Iniesta R
Diabetes Technol Ther; 2013 Feb; 15(2):136-42. PubMed ID: 23289433
[TBL] [Abstract][Full Text] [Related]
12. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.
Sherr J; Tamborlane WV; Xing D; Tsalikian E; Mauras N; Buckingham B; White NH; Arbelaez AM; Beck RW; Kollman C; Ruedy K;
Diabetes Care; 2012 Apr; 35(4):817-20. PubMed ID: 22323414
[TBL] [Abstract][Full Text] [Related]
13. Role of emerging new technologies.
Garg SK
Diabetes Technol Ther; 2008 Oct; 10(5):413-4. PubMed ID: 18715219
[No Abstract] [Full Text] [Related]
14. Prepregnancy care in women with type 1 diabetes improves HbA
Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
[TBL] [Abstract][Full Text] [Related]
15. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
16. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant hypoglycemia prediction metrics for event mitigation.
Harvey RA; Dassau E; Zisser HC; Bevier W; Seborg DE; Jovanovič L; Doyle FJ
Diabetes Technol Ther; 2012 Aug; 14(8):719-27. PubMed ID: 22690875
[TBL] [Abstract][Full Text] [Related]
18. How Should We Assess Glycemic Variability in Type 1 Diabetes? Contribution of Principal Component Analysis for Interstitial Glucose Indices in 142 Children.
Guilmin-Crépon S; Carel JC; Schroedt J; Scornet E; Alberti C; Tubiana-Rufi N
Diabetes Technol Ther; 2018 Jun; 20(6):440-447. PubMed ID: 29923773
[TBL] [Abstract][Full Text] [Related]
19. Glucose Variability: A Review of Clinical Applications and Research Developments.
Rodbard D
Diabetes Technol Ther; 2018 Jun; 20(S2):S25-S215. PubMed ID: 29916742
[TBL] [Abstract][Full Text] [Related]
20. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
